We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
+32.38%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$233M
AUM Growth
+$22.5M
(+11%)
Cap. Flow
-$30.4M
Cap. Flow
% of AUM
-13.02%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$30.1M |
| 2 |
AKRO
Akero Therapeutics
AKRO
|
+$296K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
1
DELISTED
Akero Therapeutics
AKRO
| $87.5M | 37.5% |
3,940,543
-14,315
| -0.4% | -$296K |
|
2
Precision BioSciences
DTIL
$216M
| $59.2M | 25.4% |
142,171
| – | – |
|
|
TPTX
3
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $44.1M | 18.91% |
708,233
-632,032
| -47% | -$30.1M |
|
|
APLS
4
DELISTED
Apellis Pharmaceuticals
APLS
| $30.6M | 13.13% |
1,000,000
| – | – |
|
5
VYNE Therapeutics
VYNE
$25.7M
| $6.78M | 2.91% |
20,299
| – | – |
|
|
VRNA
6
DELISTED
Verona Pharma
VRNA
| $5.03M | 2.16% |
875,000
| – | – |
|
Similar funds
OCWP
FFP
BDA
PHC
OFCM
SA
ACC
NRCM